MDGL earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E -42.00. Updated 2026-07-23.
Madrigal Pharmaceuticals (MDGL) Research Hub
Madrigal Pharmaceuticals (MDGL) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 534.49 USD (-2.23%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -42.00, market cap 12.51B. This hub links to the full technical, earnings and options research available for MDGL.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 534.49 USD (-2.23%) |
| 52-week range | 447.01 USD – 569.44 USD |
| Trend regime | Range |
| 14-day RSI | 56.5 (Bullish) |
| Trailing P/E | -42.00 |
| Market cap | 12.51B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for MDGL
Covered Call on MDGL: how it works, illustrative setup around the real 534.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MDGL: how it works, illustrative setup around the real 534.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MDGL: how it works, illustrative setup around the real 534.49 USD price, max profit/loss, breakeven and when to use it. Educational.
MDGL technical analysis: range, last 534.49 USD, RSI 56.5, 52w range 447.01 USD–569.44 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MDGL in?
Madrigal Pharmaceuticals (MDGL) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MDGL in an uptrend or downtrend?
As of 2026-09-11, MDGL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MDGL's trailing P/E ratio?
MDGL's trailing P/E is -42.00, with a market cap of 12.51B. See the earnings research page for full valuation detail.
When does MDGL next report earnings?
MDGL is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of -2.77348 USD.